Evidence map›Paper›PMID 26365409›Full record

ArticleNeuroscience letters2015

Flupirtine effectively prevents development of acute neonatal seizures in an animal model of global hypoxia.

Dayalan Sampath, Doron Shmueli, Andrew M White, Yogendra H Raol

Abstract read
In one paragraph

Article in Neuroscience letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Novel Therapeutics for Neonatal Seizures.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dayalan SampathDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado, School of Medicine, Aurora, CO 80045, United States.
Doron ShmueliDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado, School of Medicine, Aurora, CO 80045, United States.
Andrew M WhiteDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado, School of Medicine, Aurora, CO 80045, United States.
Yogendra H RaolDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado, School of Medicine, Aurora, CO 80045, United States. Electronic address: Yogendra.Raol@ucdenver.edu.
University of Colorado Denver · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
ZEBRAFISH TRANSGENIC CORE - ROCKY MOUNTAIN NEUROLOGICAL DISORDERS CORE CENTERP30NS048154 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2004 to 2020
$10.1M
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathyR01HD065534 · NICHD · UNIVERSITY OF COLORADO DENVER · PI RAOL, YOGENDRA H · 2011 to 2014
$1.1M
NCATS NIH HHS UL1 TR001082NCRR NIH HHS UL1 RR025780NICHD NIH HHS R01 HD065534NICHD NIH HHS R01HD065534NINDS NIH HHS P30 NS048154
6 · The paper itself

Abstract

Current first-line drugs for the treatment of neonatal seizures have limited efficacy and are associated with side effects. Uncontrolled seizures may exacerbate brain injury and contribute to later-life neurological disability. Therefore, it is critical to develop a treatment for neonatal seizures that is effective and safe. In early-life, when the γ-aminobutyric acid (GABA) inhibitory system is not fully developed, potassium channels play an important role in controlling excitability. An earlier study demonstrated that flupirtine, a KCNQ potassium channel opener, is more efficacious than diazepam and phenobarbital for the treatment of chemoconvulsant-induced neonatal seizures. In newborns, seizures are most commonly associated with hypoxic-ischemic encephalopathy (HIE). Thus, in the present study, we examined the efficacy of flupirtine to treat neonatal seizures in an animal model of global hypoxia. Our results showed that flupirtine dose dependently blocks the occurrence of behavioral seizures in pups during hypoxia. Additionally, flupirtine inhibits the development of hypoxia-induced clinical seizures and associated epileptiform discharges, as well as purely electrographic (subclinical) seizures. These results suggest that flupirtine is an effective anti-seizure drug, and that further studies should be conducted to determine the time window within which it's administration can effectively treat neonatal seizures.

Indexed as

Acute DiseaseAminopyridinesAnimalsAnimals, NewbornAnticonvulsantsFemaleHypoxiaKCNQ Potassium ChannelsMaleRats, Sprague-DawleySeizuresAminopyridinesAnticonvulsantsflupirtineKCNQ Potassium ChannelsFlupirtineHypoxiaNeonatal seizuresPotassium channel openerVideo-EEG monitoring

Identifiers

PMID26365409
PMCPMC4631640
OpenAlexW1855979405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.